Volume 99, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



is a common cause of bloodstream infection and methicillin-resistant (MRSA) is a growing threat worldwide. We evaluated the incidence rate of bacteremia (SAB) and MRSA from population-based surveillance in all hospitals from two Thai provinces. Infections were classified as community-onset (CO) when blood cultures were obtained ≤ 2 days after hospital admission and as hospital-onset (HO) thereafter. The incidence rate of HO-SAB could only be calculated for 2009–2014 when hospitalization denominator data were available. Among 147,524 blood cultures, 919 SAB cases were identified. Community-onset bacteremia incidence rate doubled from 4.4 (95% confidence interval [CI]: 3.3–5.8) in 2006 to 9.3 per 100,000 persons per year (95% CI: 7.6–11.2) in 2014. The highest CO-SAB incidence rate was among adults aged 50 years and older. Children less than 5 years old had the next highest incidence rate, with most cases occurring among neonates. During 2009–2014, there were 89 HO-SAB cases at a rate of 0.13 per 1,000 hospitalizations per year (95% CI: 0.10–0.16). Overall, MRSA prevalence among SAB cases was 10% (90/911) and constituted 7% (55/736) of CO-SAB and 20% (22/111) of HO-SAB without a clear temporal trend in incidence rate. In conclusion, CO-SAB incidence rate has increased, whereas MRSA incidence rate remained stable. The increasing CO-SAB incidence rate, especially the burden on older adults and neonates, underscores the importance of strong SAB surveillance to identify and respond to changes in bacteremia trends and antimicrobial resistance.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Keynan Y, Rubinstein E, , 2013. Staphylococcus aureus bacteremia, risk factors, complications, and management. Crit Care Clin 29: 547562. [Google Scholar]
  2. Boucher HW, Corey GR, , 2008. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 (Suppl 5): S344S349. [Google Scholar]
  3. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y, , 2005. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26: 166174. [Google Scholar]
  4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y, , 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36: 5359. [Google Scholar]
  5. Yaw LK, Robinson JO, Ho KM, , 2014. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 14: 967975. [Google Scholar]
  6. WHO, 2014. Antimicrobial Resistance: Global Report on Surveillance. Geneva, Switzerland: World Health Organization.
  7. Deen J, von Seidlein L, Andersen F, Elle N, White NJ, Lubell Y, , 2012. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis 12: 480487. [Google Scholar]
  8. Phetsouvanh R, Phongmany S, Soukaloun D, Rasachak B, Soukhaseum V, Soukhaseum S, Frichithavong K, Khounnorath S, Pengdee B, Phiasakha K, , 2006. Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 75: 978. [Google Scholar]
  9. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D, , 2013. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 8: e54714. [Google Scholar]
  10. Mekviwattanawong S, Srifuengfung S, Chokepaibulkit K, Lohsiriwat D, Thamlikitkul V, , 2006. Epidemiology of Staphylococcus aureus infections and the prevalence of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in hospitalized patients at Siriraj Hospital. J Med Assoc Thai 89 (Suppl 5): S106S117. [Google Scholar]
  11. Nickerson EK, 2009. Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One 4: e4308. [Google Scholar]
  12. Hongsuwan M, Srisamang P, Kanoksil M, Luangasanatip N, Jatapai A, Day NP, Peacock SJ, Cooper BS, Limmathurotsakul D, , 2014. Increasing incidence of hospital-acquired and healthcare-associated bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 9: e109324. [Google Scholar]
  13. Nickerson EK, West TE, Day NP, Peacock SJ, , 2009. Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis 9: 130135. [Google Scholar]
  14. Lestari ES, Severin Jt A, Verbrugh HA, , 2012. Antimicrobial resistance among pathogenic bacteria in southeast Asia. Southeast Asian J Trop Med Public Health 43: 385422. [Google Scholar]
  15. WHO SEARO, 2011. Jaipur Declaration on Antimicrobial Resistance. New Delhi, India: WHO Regional Office for South-East Asia.Available at: http://www.searo.who.int/entity/world_health_day/media/2011/whd-11_amr_jaipur_declaration_.pdf. Accessed July 24, 2016.
  16. Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, Limsrivilai J, Warachan B, Bailey TC, Fraser VJ, , 2006. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 42: 768775. [Google Scholar]
  17. Apisarnthanarak A, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ, , 2010. Effectiveness of a catheter-associated bloodstream infection bundle in a Thai tertiary care center: a 3-year study. Am J Infect Control 38: 449455. [Google Scholar]
  18. Korbkitjaroen M, Vaithayapichet S, Kachintorn K, Jintanothaitavorn D, Wiruchkul N, Thamlikitkul V, , 2011. Effectiveness of comprehensive implementation of individualized bundling infection control measures for prevention of health care-associated infections in general medical wards. Am J Infect Control 39: 471476. [Google Scholar]
  19. National Economic and Social Development Board of Thailand, 2012. Population Projections of Thailand 2010–2040. Bangkok, Thailand: Office of the National Economic and Social Development Board.
  20. National Economic and Social Development Board. Table of Gross Regional and Provincial Product, 1995–2012. Bangkok, Thailand: Office of the National Economic and Social Development Board.
  21. Jorgensen JH, Carroll KC, Pfaller MA, , 2015. Manual of Clinical Microbiology. Washington, DC: ASM Press.
  22. Clinical and Laboratory Standards Institute, 2014. Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement. CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute.
  23. Clinical and Laboratory Standards Institute, 2007. Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement. CLSI document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute.
  24. Cohen D, Swift G, , 2013. Laboratories and regulator misled over antibiotic susceptibility test discs: patients may have received inappropriate antibiotic treatment as a result of quality problems with one company’s test discs, Deborah Cohen and Glenn Swift report. BMJ 346: f837. [Google Scholar]
  25. Li F, Ayers TL, Park SY, Miller FD, MacFadden R, Nakata M, Lee MC, Efflert PV, , 2005. Isolate removal methods and methicillin-resistant Staphylococcus aureus surveillance. Emerg Infect Dis 11: 15521557. [Google Scholar]
  26. Driscoll AJ, Bhat N, Karron RA, O’Brien KL, Murdoch DR, , 2012. Disk diffusion bioassays for the detection of antibiotic activity in body fluids: applications for the pneumonia etiology research for child health project. Clin Infect Dis 54 (Suppl 2): S159S164. [Google Scholar]
  27. National Economic and Social Development Board of Thailand, 2007. Population Projections of Thailand 2000–2030. Bangkok: Office of the National Economic and Social Development Board.
  28. Laupland KB, The International Bacteremia Surveillance Collaborative , 2013. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 19: 465471. [Google Scholar]
  29. Klevens RM, 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 17631771. [Google Scholar]
  30. Kaasch AJ, 2014. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 68: 242251. [Google Scholar]
  31. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB, , 2012. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25: 362386. [Google Scholar]
  32. Kaye KS, Marchaim D, Chen TY, Baures T, Anderson DJ, Choi Y, Sloane R, Schmader KE, , 2014. Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc 62: 306311. [Google Scholar]
  33. Stoesser N, 2013. Pediatric bloodstream infections in Cambodia, 2007 to 2011. Pediatr Infect Dis J 32: e272e276. [Google Scholar]
  34. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, , 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 173: 19701978. [Google Scholar]
  35. Thelwall S, Nsonwu O, Bhattacharya A, Wasti S, Gerver S, Davies J, Hope R, , 2017. Annual Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data 2016/17. London, United Kingdom: Public Health England.
  36. Lim C, Takahashi E, Hongsuwan M, Wuthiekanun V, Thamlikitkul V, Hinjoy S, Day NP, Peacock SJ, Limmathurotsakul D, , 2016. Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. eLife 5: e18082. [Google Scholar]
  37. Bunnueang N, Kongpheng S, Yadrak P, Rattanachuay P, Khianngam S, Sukhumungoon P, , 2016. Methilcillin-resistant Staphylococcus aureus: 1-year collection and characterization from patients in two tertiary hospitals, southern Thailand. Southeast Asian J Trop Med Public Health 47: 234244. [Google Scholar]
  38. WHO, 2017. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2016–2017. Geneva, Switzerland: World Health Organization.
  39. Broekema NM, Van TT, Monson TA, Marshall SA, Warshauer DM, , 2009. Comparison of cefoxitin and oxacillin disk diffusion methods for detection of mecA-mediated resistance in Staphylococcus aureus in a large-scale study. J Clin Microbiol 47: 217219. [Google Scholar]
  40. WHO, 2017. Situational Analysis on Antimicrobial Resistance in the South-East Asia Region. Geneva, Switzerland: World Health Organization.
  41. Khawcharoenporn T, Apisarnthanarak A, Mundy LM, , 2013. National survey of antimicrobial stewardship programs in Thailand. Am J Infect Control 41: 8688. [Google Scholar]
  42. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, , 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52: e18e55. [Google Scholar]

Data & Media loading...

Supplemental Table

  • Received : 08 Aug 2017
  • Accepted : 26 Feb 2018
  • Published online : 14 May 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error